Account
Insider Insights
09.03.2022
Requirement lifted for a number of products

Paracetamol and ibuprofen combinations are set to become available in pharmacies without a prescript...

Read more
Insider Insights
03.03.2022
Ensuring patients have access to orphan drugs

According to the pharmaceutical industry association, Farmaindustria, 40% of orphan drugs approved i...

Read more
Insider Insights
03.03.2022
NICE recommends routine use of Zejula

The National Institute for Health and Care Excellence (NICE) has recommended GlaxoSmithKline’s Zej...

Read more
Insider Insights
02.03.2022
Use of COVID-19 treatments granted early access 20

According to the National Agency for Drug Safety, there are currently four treatments available thro...

Read more
Insider Insights
01.03.2022
Spotlight on access to orphan drugs

The Ministry of Health hhas published a report on the “evolution of funding and fixing of the pric...

Read more
Insider Insights
01.03.2022
Improved access to orphan drugs in 2021

14 new orphan drugs were made available in the national health service (Sistema Nacional de Salud, S...

Read more
Insider Insights
28.02.2022
UK first rare disease action plan

On 28th February 2022, Health and Social Care Secretary Sajid Javid launched England’s first Rare...

Read more
Insider Insights
24.02.2022
Legislation-extends-CPR-and-CTS-membership

The National Recovery and Resilience Plan had extended the membership to the CPR and CTS until 28th...

Read more
Insider Insights
21.02.2022
CNAM spending on reimbursed medicines

Reimbursed spending by the CNAM on out-patient care (including care from general practitioners [GPs]...

Read more
Insider Insights
21.02.2022
Eligibility for prescribing testosterone

The change is intended to simplify care pathways and the management of patients requiring testoster...

Read more

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.